ARV-102 reduced endolysosomal and neuroinflammatory biomarkers implicated in Parkinson’s disease and progressive supranuclear palsy –– ARV-102 ...

Additional biomarker analysis reveals higher CSF levels of DOPA decarboxylase (DDC – an emerging PD biomarker) at baseline with a reduction ...

Data represents up to 8.5 years of follow-up and are consistent across age, dose, and genotype BLA resubmitted to U.S. FDA in January 2026; Company expects up to six-month review period per FDA ...

The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for ...

Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to ...

A two-week-old baby was hospitalized at Wolfson after contracting herpes during a circumcision involving direct oral suction.

Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory loss?That’s the ...

There’s a virus you may have never heard of before that is estimated to infect up to 90 percent of people and lurks quietly ...

Cerebral folate deficiency is a rare neurological disorder characterized by a decrease in CSF folate levels, leading to developmental regression, seizures, movement disorders, and other neurological ...

ACI-7104 Phase 2 data and mid-2026 readout, plus FY25 cash burn and dilution risk—see key catalysts and what to do now.